News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy
Miguel Lopez de Rodas Gregorio/medicine.yale.edu
Jan 21, 2025, 06:22

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy

A recent paper by Miguel Lopez de Rodas, Associate Research Scientist in Pathology at Yale Cancer Center, was mentioned by Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, on X

“Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach”

Authors: Miguel Lopez de Rodas, Maria Villalba-Esparza, Miguel Sanmamed, Lieping Chen, David Rimm and Kurt Schalper.

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy

“Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.

Biological properties and biomarker potential for ICI therapy.”

More posts featuring Hidehito Horinouchi.

cancer David Rimm Hidehito Horinouchi Kurt Schalper Lieping Chen Maria Villalba-Esparza Miguel Lopez de Rodas Miguel Sanmamed OncoDaily Oncology
Special Coverage
Insight
Feb 21, 2025, 06:20
Gustavo Viani: New Evidence on Elective CTV in Early Anal Cancer
Blog
Feb 21, 2025, 06:10
Afreen Shariff: Start-ups are about persistence, grit and being comfortable with being uncomfortable
Radiotherapy
Feb 21, 2025, 04:51
Radiotherapy For Breast Cancer: Types, Success Rate, Side Effects And More
Library
Feb 20, 2025, 16:36
New Paper Alert: Systemic management of advanced HCC: an increasingly complex game
Blog
Feb 20, 2025, 14:43
MD Anderson Cancer Center and Texas Children's Hospital announced a collaboration dedicated solely to pediatric cancer care
Blog
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Blog
Feb 20, 2025, 11:19
Jill Feldman: My Guiding Compass in Advocacy
Blog
Feb 20, 2025, 11:13
Abstract submissions are open for the ESMO Gynae25
Blog
Feb 20, 2025, 11:08
Aleix Prat: In ten years we will cure 80% of cancers
Blog
Feb 20, 2025, 11:00
Akshaya Keerti: PCOS and the Hidden Risk of Endometrial Cancer
Blog
Feb 20, 2025, 10:53
Fumiko Ladd Chino: Optimizing the EHR for patient-centered communication and care
Blog
Feb 20, 2025, 10:52
Rob Winn: Our partners are what make the miracle medicines possible